Doug Drysdale

Doug Drysdale is the Chief Executive Officer of Cybin. During Doug’s tenure as CEO of Cybin, the company was taken public on the NYSE and now has two clinical-stage programs in development for the treatment of major depressive disorder and generalized anxiety disorder, with its lead depression program in Phase 3 trials.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.